These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Menelas Pangalos. Interview by Asher Mullard. Mullard A Nat Rev Drug Discov; 2013 Jun; 12(6):418. PubMed ID: 23722338 [No Abstract] [Full Text] [Related]
8. An audience with...Francis Collins. Interviewed by Asher Mullard. Collins F Nat Rev Drug Discov; 2011 Jan; 10(1):14. PubMed ID: 21151031 [No Abstract] [Full Text] [Related]
9. Mark Fishman. Interview by Asher Mullard. Fishman M Nat Rev Drug Discov; 2012 Jan; 11(1):14-5. PubMed ID: 22212670 [No Abstract] [Full Text] [Related]
10. An audience with... Susan Desmond-Hellmann. Interview by... Asher Mullard. Desmond-Hellmann S Nat Rev Drug Discov; 2011 Mar; 10(3):170. PubMed ID: 21358729 [No Abstract] [Full Text] [Related]
11. An audience with… Henry Chesbrough. Interview by Asher Mullard. Chesbrough H Nat Rev Drug Discov; 2013 May; 12(5):338-9. PubMed ID: 23598507 [No Abstract] [Full Text] [Related]
12. An audience with Thomas Lönngren. Interview by Asher Mullard. Lönngren T Nat Rev Drug Discov; 2010 Dec; 9(12):912. PubMed ID: 21119726 [No Abstract] [Full Text] [Related]
13. [Dismantling of "Big Pharma" gives new impetus to the pharmaceutical sector. Dynamic life science clusters can increase Swedish competitiveness]. Hedner T; Gatenbeck L Lakartidningen; 2012 Jun 27-Jul 17; 109(26-28):1280-1. PubMed ID: 22852257 [No Abstract] [Full Text] [Related]
15. Vertical disintegration: a strategy for pharmaceutical businesses in 2009? Dixon J; Lawton G; Machin P Nat Rev Drug Discov; 2009 Jun; 8(6):435. PubMed ID: 19483701 [No Abstract] [Full Text] [Related]
16. Michael Snyder. Interview by Asher Mullard. Snyder M Nat Rev Drug Discov; 2012 Oct; 11(10):744. PubMed ID: 23023673 [No Abstract] [Full Text] [Related]
17. Mark McClellan. Interview by Asher Mullard. McClellan M Nat Rev Drug Discov; 2012 Sep; 11(9):668. PubMed ID: 22935796 [No Abstract] [Full Text] [Related]
18. Open partnering of integrated drug discovery: continuing evolution of the pharmaceutical model. Hutchins S; Torphy T; Muller C Drug Discov Today; 2011 Apr; 16(7-8):281-3. PubMed ID: 21335101 [No Abstract] [Full Text] [Related]
19. An audience with... Tachi Yamada. Interviewed by Asher Mullard. Yamada T Nat Rev Drug Discov; 2013 Sep; 12(9):658-9. PubMed ID: 23989787 [No Abstract] [Full Text] [Related]
20. Drug discovery management, small is still beautiful: Why a number of companies get it wrong. Knutsen LJ Drug Discov Today; 2011 Jun; 16(11-12):476-84. PubMed ID: 21504798 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]